Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation Is Well Tolerated, Induces Anti-Tumor Immunity and May Lead to Eradication of Measureable Disease
Year: 2015
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Jacalyn Rosenblatt, Irit Avivi, Noam Binyamini, Lynne Uhl, Poorvi Somaiya, Dina Stroopinsky, Kristen Anna Palmer, Maxwell Douglas Coll, Tami Katz, Lina Bisharat, Robin Joyce, James D. Levine, Jon E. Arnason, Katarina Luptakova, Malgorzata McMasters, Salvia Jain, Merav Leiba, Aya Sato-Dilorenzo, Emma Logan, Mary Paty Bryant, Viki Held, Paul G. Richardson, Jacob P. Laubach, Arnon Nagler, Kenneth C. Anderson, Nikhil C. Munshi, Jacob M. Rowe, Donald Kufe, David Avigan
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2489390499
